Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Talya, El-Leithy, Sharif, Billings, Jo, Albert, Idit, Birch, Jennifer, Campbell, Mari, Ehntholt, Kim, Fortune, Lorna, Gilbert, Nicola, Grey, Nick, Hana, Laurinne, Kennerley, Helen, Lee, Deborah, Lunn, Sarah, Murphy, Dominic, Robertson, Mary, Wade, Dorothy, Brewin, Chris R., Bloomfield, Michael A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797726/
https://www.ncbi.nlm.nih.gov/pubmed/35096282
http://dx.doi.org/10.1080/20008198.2021.1959707
Descripción
Sumario:Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

Ejemplares similares